Cytex Therapeutics, Inc. — Form D

Cytex Therapeutics, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2025-01-10. The offering totals $2.0M, of which $125K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-01-10
• Form: D
• Accession: 0001943908-25-000001
• Industry: Biotechnology
• Exemptions: 06c
• Total offering: $2.0M
• Amount sold: $125K
• Remaining: $1.9M
• Minimum investment: $10K
• Investors: 2
• Date of first sale: 2024-11-27
• Security types: debt
• Revenue range: $1,000,001 - $5,000,000
• SEC file number: 021-534704

Issuer

• Name: Cytex Therapeutics, Inc.
• CIK: 0001943908
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 2609 N. DUKE STREET, DURHAM, NC, 27704
• Phone: 919.912.9839

Officers, directors & promoters (7)

More

• CIK 1943908 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search